
DexCom (DXCM) Stock Forecast & Price Target
DexCom (DXCM) Analyst Ratings
Bulls say
DexCom is a leader in the growing market of continuous glucose monitoring systems, with a strong management team and a scalable business model. This outlook is supported by the company's latest clinical trial data, which showed significant improvements in A1c and time in range for type 2 diabetic patients using the company's CGM system. While pricing headwinds may exist in the future, the potential for increased adoption by non-intensive type 2 patients and expansion in international markets should drive significant upside for DexCom.
Bears say
DexCom is facing potential challenges in increasing their CGM penetration in the US market, and the company's competitive advantage may be reduced by competition from other products. Furthermore, future product releases may face delays due to regulatory barriers, and the company's stock may continue to trade at a high premium multiple, posing risks to potential investors.
This aggregate rating is based on analysts' research of DexCom and is not a guaranteed prediction by Public.com or investment advice.
DexCom (DXCM) Analyst Forecast & Price Prediction
Start investing in DexCom (DXCM)
Order type
Buy in
Order amount
Est. shares
0 shares